Find trials
Search tips

A Study to Evaluate the Ability of a Newly Developed Sperm Antibody to Attach to Human Sperm from Men with Normal Sperm Counts

Overview

About this study

The primary objective of this study is to evaluate the ability of a newly developed sperm antibody to successfully attach to human sperm from men with normal sperm counts.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  1. Males being seen at Mayo Clinic Rochester for suspected male infertility
  2. >18 years old

Exclusion Criteria

  1. None

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Landon Trost, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20424135

Mayo Clinic Footer